EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Epigenetic modulators provide a path to understanding disease and therapeutic opportunity

Madison A Honer, Benjamin I Ferman, Zach H Gray, Elena A Bondarenko, Johnathan R Whetstine

Genes & Development · 01.06.2024 · 38 (11-12) · 473-503

DOI: 10.1101/gad.351444.123 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes & Development, online erschienen am 24.06.2024. Verfasst von Madison A Honer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA. Hauptthemen laut MEDLINE: Epigenesis, Genetic. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 385 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Institutes of Health/National Cancer Institue Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The discovery of epigenetic modulators (writers, erasers, readers, and remodelers) has shed light on previously underappreciated biological mechanisms that promote diseases. With these insights, novel biomarkers and innovative combination therapies can be used to address challenging and difficult to treat disease states. This review highlights key mechanisms that epigenetic writers, erasers, readers, and remodelers control, as well as their connection with disease states and recent advances in associated epigenetic therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epigenesis, GeneticHumansAnimalsDNA MethylationDisease

Stichwörter der Autor:innen

DNA and histone modificationsDNA methylationSWI/SNFacetylationbromodomainchromatin remodelingdemethylaseecDNAepigeneticstranscription

Autor:innen und Institutionen

  • Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
  • Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
  • Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
  • Biomedical Sciences Program, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania 19140, USA.
  • Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA; johnathan.whetstine@fccc.edu.

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health/National Cancer Institue Cancer Center

Zitieren

APA

Honer, M. A., Ferman, B. I., Gray, Z. H., Bondarenko, E. A., & Whetstine, J. R. (2024). Epigenetic modulators provide a path to understanding disease and therapeutic opportunity. Genes & Development, 38(11-12), 473-503. https://doi.org/10.1101/gad.351444.123

Vancouver

Honer MA, Ferman BI, Gray ZH, Bondarenko EA, Whetstine JR. Epigenetic modulators provide a path to understanding disease and therapeutic opportunity. Genes & Development. 2024;38(11-12):473-503. doi:10.1101/gad.351444.123

BibTeX
@article{Honer2024,
  author = {Honer, Madison A and Ferman, Benjamin I and Gray, Zach H and Bondarenko, Elena A and Whetstine, Johnathan R},
  title = {Epigenetic modulators provide a path to understanding disease and therapeutic opportunity},
  journal = {Genes & Development},
  year = {2024},
  volume = {38},
  number = {11-12},
  pages = {473--503},
  doi = {10.1101/gad.351444.123}
}
Kostenlos starten →